Boehringer Ingelheim Vetmedica, Inc.
Pet Division
3902 Gene Field Road
St. Joseph, Missouri 64506
- Phone 866-638-2226
- Fax 816-326-9167
Value Through Innovation14 June 2013
Metacam®
(meloxicam)
METACAM offers an easy, effective way to treat pain effectively. Whether relieving the pain of osteoarthritis in large or small breed dogs or treating pain preemptively in cats prior to surgery, METACAM provides highly effective pain management that's rewarding for patients, practitioners, and owners alike. METACAM is the only injectable NSAID licensed for both cats and dogs in the US. It is also the only approved oral liquid NSAID for dogs with osteoarthritis in the US.
METACAM Solution for Injection
- Cats
Indicated in cats for the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration when administered prior to surgery.
- Dogs
Indicated in dogs for the control of pain and inflammation associated with osteoarthritis
METACAM Oral Suspension
- Dogs only
Indicated in dogs for the control of pain and inflammation associated with osteoarthritis. Only METACAM is available in an oral liquid form that makes it easy to titrate to the lowest dose that is effective in each patient.
As a class, cyclo-oxygenase inhibitory NSAIDs may be associated with gastrointestinal, kidney, or liver side effects. The most common side effects reported in field studies were vomiting and soft stool/diarrhea. These are usually mild, but may be serious. If side effects occur, pet owners should halt therapy and contact their veterinarian. Pets should be evaluated for pre-existing conditions and currently prescribed medications prior to treatment with METACAM, then monitored regularly while on treatment. Concurrent use with another NSAID, corticosteroid, or nephrotoxic medication should be avoided.
The safe use of METACAM Oral Suspension and Solution for Injection in dogs younger than 6 months of age, dogs used for breeding, or in pregnant or lactating dogs has not been evaluated.
The safe use of Metacam 5 mg/mL Solution for Injection in cats younger than 4 months of age, cats used for breeding, or in pregnant or lactating queens has not been evaluated. Repeated use of meloxicam in cats has been associated with acute renal failure and death. Do not administer a second dose of meloxicam. Do not follow meloxicam dose with any other NSAID.
CAUTION: Federal Law restricts this drug to use by or on the order of a licensed veterinarian.
Important Safety Information
As a class, cyclo-oxygenase inhibitory NSAIDs may be associated with gastrointestinal, kidney, or liver side effects. The most common side effects reported in field studies were vomiting and soft stool/diarrhea. These are usually mild, but may be serious. If side effects occur, pet owners should halt therapy and contact their veterinarian. Pets should be evaluated for pre-existing conditions and currently prescribed medications prior to treatment with METACAM, then monitored regularly while on treatment. Concurrent use with another NSAID, corticosteroid, or nephrotoxic medication should be avoided.
The safe use of METACAM Oral Suspension and Solution for Injection in dogs younger than 6 months of age, dogs used for breeding, or in pregnant or lactating dogs has not been evaluated.
The safe use of Metacam 5 mg/mL Solution for Injection in cats younger than 4 months of age, cats used for breeding, or in pregnant or lactating queens has not been evaluated. Repeated use of meloxicam in cats has been associated with acute renal failure and death. Do not administer a second dose of meloxicam. Do not follow meloxicam dose with any other NSAID.
CAUTION: Federal Law restricts this drug to use by or on the order of a licensed veterinarian.
For Dogs
- Solution for Injection: METACAM 5mg/mL Solution for Injection should be administered initially as a single dose at 0.09 mg/lb (0.2mg/kg) body weight intravenously (IV) or subcutaneously (SQ), followed after 24 hours, by METACAM Oral Suspension at the daily dose of 0.045 mg/lb (0.1mg/kg) body weight, either mixed with food or placed directly in the mouth.
- Oral Suspension: Administer initially as a single dose at 0.09mg/lb (0.2mg/kg) body weight on the first day of treatment. For all treatments after day 1, METACAM Oral Suspension should be administered once daily at a dose of 0.045mg/lb (0.1mg/kg) either mixed with food or placed directly into the mouth. The syringe is calibrated to deliver the daily maintenance dose in pounds. See package insert for complete weight information.
For Cats
- Solution for Injection: Administer a single, one-time subcutaneous dose of METACAM 5mg/mL Solution for Injection to cats at a dose of 0.14mg/lb (0.3mg/kg) body weight. To ensure accurate dosing, the use of a 1mL graduated syringe is recommended.
Important Safety Information
As a class, cyclo-oxygenase inhibitory NSAIDs may be associated with gastrointestinal, kidney, or liver side effects. The most common side effects reported in field studies were vomiting and soft stool/diarrhea. These are usually mild, but may be serious. If side effects occur, pet owners should halt therapy and contact their veterinarian. Pets should be evaluated for pre-existing conditions and currently prescribed medications prior to treatment with METACAM, then monitored regularly while on treatment. Concurrent use with another NSAID, corticosteroid, or nephrotoxic medication should be avoided.
The safe use of METACAM Oral Suspension and Solution for Injection in dogs younger than 6 months of age, dogs used for breeding, or in pregnant or lactating dogs has not been evaluated.
The safe use of Metacam 5 mg/mL Solution for Injection in cats younger than 4 months of age, cats used for breeding, or in pregnant or lactating queens has not been evaluated. Repeated use of meloxicam in cats has been associated with acute renal failure and death. Do not administer a second dose of meloxicam. Do not follow meloxicam dose with any other NSAID.
CAUTION: Federal Law restricts this drug to use by or on the order of a licensed veterinarian.
